Evan Godt, Molecular Imaging reports on February 19, 2013 that Demographic differences in the use of PET imaging among Medicare beneficiaries with non-small cell lung cancer (NSCLC) have persisted since the modality’s approval by Medicare in 1998, according to a study published online Feb. 15 in Radiology.